Black Friday Sale - 20% off Storewide! Free Express shipping on all orders $100+ | Australia Wide Same day dispatch on orders before 12pm
Black Friday Sale - 20% off Storewide! Free Express shipping on all orders $100+ | Australia Wide Same day dispatch on orders before 12pm
Research guide

What Is SS-31? Elamipretide Research Guide

SS-31 explained: the peptide with no receptor, what cardiolipin and cristae are, why it is not an antioxidant, vs MOTS-c, and 10mg vial reconstitution volumes.

What Is SS-31? Elamipretide Research Guide

SS-31 vs MOTS-c

SS-31 MOTS-c
Origin Fully synthetic Coded in mitochondrial DNA
Length 4 amino acids 16 amino acids
Mechanism Binds cardiolipin in the membrane AMPK activation and nuclear signalling
Type of effect Structural Signalling
Studied for Membrane integrity, ROS output Cellular energy sensing
Receptor or target A lipid A pathway

SS-31 is four amino acids long and does something nothing else in this catalogue does: it has no receptor. Instead of docking at a receptor and triggering a signal, it accumulates inside mitochondrial membranes and binds a specific lipid there called cardiolipin. The effect being studied is structural rather than signalling.

It is written SS-31, SS31 and SS-31 peptide, and its formal name is Elamipretide. This guide covers how the sequence was designed, what cardiolipin is and why it matters, what the cristae are, how it differs from MOTS-c, where the SS name comes from, reconstitution volumes, and how to check a batch. SS-31 is supplied by PhaseOne in 10mg vials, strictly for laboratory research.

Key points at a glance

  • A synthetic tetrapeptide, four amino acids, CAS 736992-21-5
  • Sequence D-Arg-Dmt-Lys-Phe-NH2, deliberately alternating charged and bulky residues
  • Formally named Elamipretide; written SS-31, SS31 and SS-31 peptide
  • SS stands for Szeto-Schiller, the researchers behind the series it belongs to
  • Has no receptor. It accumulates in mitochondrial membranes and binds cardiolipin
  • The studied effect is structural: holding membrane organisation together
  • Reduced reactive oxygen species output is studied as a downstream consequence, not the mechanism
  • Mechanistically unrelated to MOTS-c, despite both being called mitochondrial peptides
  • Supplied in 10mg vials, at least 99% HPLC purity, certificate published publicly

What is SS-31?

The sequence is D-Arg-Dmt-Lys-Phe-NH2, and almost every part of it is a deliberate choice rather than a natural one.

Two residues carry a positive charge, arginine and lysine. Two are bulky and aromatic, a dimethyltyrosine and a phenylalanine. They alternate. The charge is what pulls the molecule toward the mitochondrial membrane, which carries a strong negative potential, and the bulk is part of what keeps it there once it arrives.

The D-arginine is also not the form the body uses. Natural peptides are built from L-amino acids, and enzymes that cut peptides apart expect to find them. Swapping in a D form, plus the non-standard Dmt residue, makes the molecule much harder to degrade.

SS-31 at a glance
PropertySS-31
CAS number736992-21-5
Formal nameElamipretide
SequenceD-Arg-Dmt-Lys-Phe-NH2
Length4 amino acids (tetrapeptide)
SeriesSzeto-Schiller peptides
Also writtenSS31, SS-31 peptide
TargetCardiolipin, in the inner mitochondrial membrane
Vial size supplied10mg lyophilised powder
Purity standardGreater than or equal to 99% by HPLC
The SS-31 tetrapeptide sequence

No receptor involved

This is the part worth slowing down on, because it puts SS-31 in a different class from everything else on this site.

A receptor-agonist peptide works by fitting a receptor, which then sets off a cascade inside the cell. The peptide itself does very little; it delivers a message. SS-31 has no receptor. It physically concentrates in a membrane and attaches to a lipid in it.

That changes what kind of claim is even being made. With a secretagogue you are asking what signal was sent. With SS-31 you are asking whether a structure held its shape. It also means the usual vocabulary of receptor affinity and agonism simply does not apply here.

SS-31 membrane targeting compared with receptor-agonist peptides

What cardiolipin is

Cardiolipin is a phospholipid, which is to say a fat molecule that makes up part of a membrane. What makes it unusual is where it lives: almost exclusively in the inner mitochondrial membrane, barely anywhere else in the cell. That is what makes it a useful target, because binding it means acting on mitochondria specifically.

Its job is organisational. The electron transport chain is a set of large protein complexes that have to sit in the right arrangement relative to one another to pass electrons along efficiently, and cardiolipin is part of what holds that arrangement in place.

Cardiolipin is also vulnerable. Under oxidative stress it can become peroxidised, meaning chemically damaged, and a peroxidised cardiolipin no longer organises the complexes the way an intact one does. SS-31 is studied for binding cardiolipin and keeping that organisation stable.

Cardiolipin intact compared with peroxidised, and where SS-31 binds

Cristae and why shape matters

Cristae are the folds in the inner mitochondrial membrane. They are not decorative: folding the membrane packs far more surface area into the same volume, and that surface is where ATP production is concentrated.

Under conditions of mitochondrial dysfunction, cristae architecture is observed to break down, and the folds flatten or fragment. Less organised surface means less efficient energy production. SS-31 research examines whether stabilising cardiolipin helps preserve that folded structure.

The causal chain being proposed runs: bind cardiolipin, keep the complexes arranged, keep the cristae folded, keep the bioenergetics working. Each link in that chain is studied, and the first is better established than the last.

The ROS connection

Reactive oxygen species, usually shortened to ROS, are reactive byproducts generated when electrons leak out of the transport chain instead of travelling the intended route. Some leakage is normal; a lot is damaging.

The connection to SS-31 is indirect and worth stating precisely, because it is often presented as though SS-31 were an antioxidant. It is not described as scavenging ROS. The proposal is that disorganised complexes leak more electrons, so keeping them organised means less leakage, so less ROS gets produced in the first place.

Prevention upstream rather than cleanup downstream. That distinction matters when reading results, because the two mechanisms would predict different things.

SS-31 vs MOTS-c

Both get filed under mitochondrial peptides and the label is where the similarity ends. MOTS-c is a signalling molecule; SS-31 is a structural one.

Two unrelated mechanisms under one label
SS-31MOTS-c
OriginFully syntheticCoded in mitochondrial DNA
Length4 amino acids16 amino acids
MechanismBinds cardiolipin in the membraneAMPK activation and nuclear signalling
Type of effectStructuralSignalling
Studied forMembrane integrity, ROS outputCellular energy sensing
Receptor or targetA lipidA pathway

A researcher working on mitochondrial dysfunction could reasonably use both, because they address different questions: does the machinery hold its shape, and what does the cell do about its energy state. Neither result tells you about the other. The metabolic peptide guide covers the wider category, and NAD+ is the third compound that gets grouped in here on cellular-energy grounds.

Where the SS name comes from

SS stands for Szeto-Schiller, the two researchers whose work produced this family of small mitochondria-targeted peptides. The number is a series index, so SS-31 is one of a set rather than a standalone compound.

It is by far the most studied of them, which is why it is the one that reached a formal name, Elamipretide, and the one suppliers stock. If you see SS-20 or other numbers referenced in the literature, those are siblings from the same programme and PhaseOne does not supply them.

Reconstituting a 10mg SS-31 vial

SS-31 arrives as a lyophilised powder and is reconstituted with bacteriostatic water . Units are on a 100 unit U-100 syringe.

Reconstitution volumes for a 10mg SS-31 vial
Bacteriostatic water addedConcentration1mg draw2mg draw5mg draw
1ml10mg/ml0.10ml, 10 units0.20ml, 20 units0.50ml, 50 units
2ml5mg/ml0.20ml, 20 units0.40ml, 40 units1.00ml, 100 units
3ml3.3mg/ml0.30ml, 30 units0.60ml, 60 unitstwo draws
5ml2mg/ml0.50ml, 50 units1.00ml, 100 unitstwo draws

2ml to 3ml is the practical middle ground. Note that at the lower concentrations a 5mg amount exceeds what a 1ml syringe holds, which the table flags rather than hiding. Work out any combination with the Peptide Calculator , and see the reconstitution guide for technique.

Add the water slowly down the vial wall, swirl rather than shake, then refrigerate once dissolved and keep it out of light. The storage guide covers the stability variables in full.

What the research does not establish

SS-31 has a broader research base than most compounds here, spanning cellular and animal-model work across several tissue types. That breadth is a genuine strength and it also creates a specific trap.

  • Breadth is not depth. SS-31 has been examined in many different tissue models, which is not the same as being well established in any one of them.
  • The cardiolipin binding is the best supported link in the chain. Cristae preservation is less settled, and the bioenergetic consequence less again. The further down the proposed chain a claim sits, the weaker the ground.
  • It is not an antioxidant and should not be described as one. The ROS proposal is about preventing leakage upstream, not neutralising species after they form.
  • Findings in one organ-system model do not transfer to another, and the breadth of the literature makes that mistake unusually easy to make.

The compound having a formal name and a clinical development history does not change its status here: it is not registered on the ARTG and is supplied for laboratory research only.

Checking purity before you order

SS-31 is harder to make than its length suggests. A four residue peptide sounds trivial, but two of those residues are non-standard: a D-amino acid and dimethyltyrosine, which is not something you pull off a shelf. Getting the D form right matters, because the L form would be a different molecule that enzymes would clear quickly.

So the question for a certificate here is identity as much as purity. A high purity figure on the wrong stereochemistry is not the compound you ordered.

Every PhaseOne batch is independently tested to a standard of at least 99% purity by HPLC, and the certificate for each batch is published in our public COA library . You can read the result before ordering rather than taking a claim on trust. No COA is shipped with the vial; it is simply public.

For how to read a chromatogram, see the HPLC testing guide , and for what any supplier should be able to show you, the research standards guide .

Example HPLC chromatogram

Buying SS-31 in Australia

PhaseOne supplies SS-31 in 10mg vials from Australian stock, shipped Australia-wide, for laboratory research only, with every batch HPLC tested to at least 99% purity and the certificate published publicly.

Two checks specific to this compound. Does the certificate confirm the sequence including the D-arginine and the Dmt residue, rather than only reporting purity? And is the listing selling SS-31 specifically, rather than another member of the Szeto-Schiller series?

Researchers working mitochondrial questions from the signalling side usually pair it with MOTS-c or NAD+ as a contrast. Browse the full research range .

For the mitochondrial-derived peptide comparison, the MOTS-c guide . For the coenzyme that comes up alongside both, the NAD+ guide . For the category, the metabolic peptide guide . For handling, the reconstitution guide and storage guide . For verification, the HPLC testing guide and the COA library .

Frequently Asked Questions

What is SS-31 in simple terms?

A synthetic four amino acid peptide, sequence D-Arg-Dmt-Lys-Phe-NH2, that accumulates in mitochondrial membranes and binds a lipid called cardiolipin. Unusually for a peptide, it has no receptor.

Is SS31 the same as SS-31?

Yes. SS-31, SS31 and SS-31 peptide all refer to the same compound. Its formal name is Elamipretide.

What does the SS in SS-31 stand for?

Szeto-Schiller, the researchers behind the series of small mitochondria-targeted peptides it belongs to. The number is a series index, so SS-31 is one of a set.

Is SS-31 the same as Elamipretide?

Yes. Elamipretide is the formal name for the same molecule. What PhaseOne supplies is a research-grade vial, not a pharmaceutical product.

Why does SS-31 have no receptor?

Because it was designed to work on structure rather than signalling. The charged residues pull it toward the negatively charged mitochondrial membrane, where it binds cardiolipin directly rather than docking at a receptor.

What is cardiolipin?

A phospholipid found almost exclusively in the inner mitochondrial membrane. It helps hold the electron transport chain complexes in the right arrangement, and that near-exclusive location is what makes it a mitochondria-specific target.

What are cristae?

The folds in the inner mitochondrial membrane. Folding packs more surface area into the same volume, and that surface is where ATP production is concentrated, so the shape has functional consequences.

Is SS-31 an antioxidant?

No, and this is a common error. It is not described as neutralising reactive oxygen species. The proposal is that keeping the transport chain organised means fewer electrons leak, so less ROS is produced in the first place.

Why are two of the amino acids unusual?

The D-arginine is the mirror image of the form the body uses, and dimethyltyrosine is non-standard. Enzymes that cut peptides expect L-amino acids, so both substitutions make the molecule much harder to degrade.

Is SS-31 the same category as MOTS-c?

No. Both get called mitochondrial peptides, but SS-31 binds a lipid and acts structurally, while MOTS-c is coded in mitochondrial DNA and acts through AMPK signalling. Neither result tells you about the other.

How does SS-31 compare with NAD+?

All three of SS-31, MOTS-c and NAD+ get grouped on cellular-energy grounds, and all three work differently. NAD+ is a coenzyme, MOTS-c is a signalling peptide, SS-31 is a membrane-binding structural compound.

What vial size does SS-31 come in?

10mg of lyophilised powder.

How much bacteriostatic water should a 10mg SS-31 vial be reconstituted with?

2ml to 3ml is the practical middle ground, giving 5mg/ml or 3.3mg/ml. At the lower concentrations a 5mg amount exceeds a 1ml syringe, so the table above flags where two draws would be needed.

How should SS-31 be stored?

Lyophilised vials refrigerated and out of light. Once reconstituted, refrigerate immediately, keep it dark, and prepare only what the work needs.

Does SS-31 have a lot of research behind it?

It has unusually broad research, across several tissue and organ-system models. Breadth is not the same as depth, though, and being examined in many models is not the same as being well established in any one of them.

How is SS-31 purity verified?

By independent HPLC testing. Identity matters as much as purity here, because the molecule contains a D-amino acid and a non-standard residue, and the wrong stereochemistry would be a different compound entirely.

What purity is PhaseOne SS-31?

At least 99% by independent HPLC testing, with the certificate for each batch published in our public COA library.

Does a COA come with the vial?

No. Certificates are not shipped with orders. Every batch certificate is published in our public COA library instead, so anyone can check a result before buying.

Is SS-31 approved in Australia?

No. It is not registered on the ARTG and is not approved for supply as a medicine here. It is supplied through research suppliers for laboratory research only.

Where can I buy SS-31 peptide in Australia?

PhaseOne supplies SS-31 10mg vials from Australian stock, shipped Australia-wide, for laboratory research only, with batch-specific HPLC certificates published publicly.

Disclaimer

All products supplied by PhaseOne are intended strictly for laboratory research purposes only. Products are not intended for human consumption, therapeutic use, cosmetic use, veterinary use, or diagnostic applications.

Written by
PhaseOne Research Team
Last updated 4 October 2026

Contact us